logo
ResearchBunny Logo
A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responses

Medicine and Health

A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responses

C. A. Arbeláez, J. Estrada, et al.

This groundbreaking study by Carlos A. Arbeláez and team explores a novel nanoparticle vaccine that targets neoantigens to boost antitumor T cell responses. Utilizing KRAS G12D mutations, they demonstrated that the innovative SLP-Lpx approach outperforms conventional vaccines in tumor suppression, especially when combined with checkpoint inhibitors.

00:00
00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny